214 related articles for article (PubMed ID: 5109508)
1. Fibrinogen turnover during the treatment with xantinol nicotinate.
Cultrera G; Giarola P; Gibelli A; Baldoni E; Cuttin S; Galetti G; Serenth'a P
Arzneimittelforschung; 1971 Jul; 21(7):954-7. PubMed ID: 5109508
[No Abstract] [Full Text] [Related]
2. Fibrinogen turnover and drugs acting on fibrinolysis.
De Nicola P
Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
[No Abstract] [Full Text] [Related]
3. Fibrinogen turnover in the aged subjects following the administration of drugs acting on fibrinolysis.
De Nicola P; Cultrera G; Manai G
Farmaco Sci; 1968 Oct; 23(10):994-8. PubMed ID: 5712798
[No Abstract] [Full Text] [Related]
4. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
Bouvier CA; Berthoud S
Helv Med Acta; 1968 Mar; 34(2):170-86. PubMed ID: 4232105
[No Abstract] [Full Text] [Related]
5. [Fibrinolytic action of Complamin (R). Preliminary report].
Harel P; Gauthier J
Union Med Can; 1966 May; 95(5):542-5. PubMed ID: 5932651
[No Abstract] [Full Text] [Related]
6. [Kinin liberation by xantinol nicotinate?].
Seidel G; Wentz U
Arzneimittelforschung; 1972 Jun; 22(6):1012-3. PubMed ID: 5068347
[No Abstract] [Full Text] [Related]
7. [Research on the fibrinolytic effects developed in vivo from 7-(2-[pyrid(3)yl-methylamino]ethyl) theophylline nicotinate. Preliminary note].
Preliminare N
Clin Ter; 1974 Nov; 71(4):321-33. PubMed ID: 4459005
[No Abstract] [Full Text] [Related]
8. [Nicotinic acid blood levels after application of xanthinolnicotinate in a new galenic retard preparation].
Brenner G
Arzneimittelforschung; 1975 Feb; 25(2):237-40. PubMed ID: 1173039
[TBL] [Abstract][Full Text] [Related]
9. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
Tesi M; Brunetti S; Caramelli L
Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
[No Abstract] [Full Text] [Related]
10. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
Robertson BR
Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287
[No Abstract] [Full Text] [Related]
11. Investigations on the action of pethidine during increased fibrinolytic acitivity in the blood of rats.
Malinowska L
Anaesth Resusc Intensive Ther; 1974; 2(2):113-21. PubMed ID: 4455100
[No Abstract] [Full Text] [Related]
12. [Influence of xantinol nicotinate on blood sugar level and free fatty acids in rats].
Brenner G
Arzneimittelforschung; 1971 Aug; 21(8):1179-83. PubMed ID: 5110015
[No Abstract] [Full Text] [Related]
13. Effects of thrombin infusions upon 131-I-labelled fibrinogen in dogs.
Nordström S; Zetterqvist E
Acta Physiol Scand; 1968; 72(1):85-99. PubMed ID: 5301454
[No Abstract] [Full Text] [Related]
14. [Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid].
Kiseleva LN; Romanenko GK
Klin Med (Mosk); 1966 Jan; 44(1):48-50. PubMed ID: 5988141
[No Abstract] [Full Text] [Related]
15. Comparative research on the fibrinolytic action of different nicotinic acid derivatives following their prolonged administration into rabbits.
De Nicola P; Gibelli A; Turazza G
Thromb Diath Haemorrh; 1966 Jan; 15(1):231-7. PubMed ID: 5919803
[No Abstract] [Full Text] [Related]
16. [Plasma fibrinogen level and the metabolism of fibrinogen-I-131 in rats treated with hydrocortisone].
Byshevskii ASh; Koigushskaia GP
Vopr Med Khim; 1973; 19(2):152-6. PubMed ID: 4267635
[No Abstract] [Full Text] [Related]
17. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
[No Abstract] [Full Text] [Related]
18. Effect of nicotinic acid on fibrinolytic activity in health, in thrombotic disease and in liver cirrhosis.
Robertson BR
Acta Chir Scand; 1971; 137(7):643-8. PubMed ID: 5149150
[No Abstract] [Full Text] [Related]
19. [Blood circulation increase in various organs following xantinol-nicotinate treatment in the acute animal experiment].
Winter R; Schmitt G; Knoche H
Arzneimittelforschung; 1973 May; 23(5):652-3. PubMed ID: 4740205
[No Abstract] [Full Text] [Related]
20. [Variations in fibrinolytic activity and fibrinogen caused by xanthinol nicotinate in cases of diabetes mellitus with peripheral vascular lesions].
Ipbüker A; Bayer H
Turk Tip Cemiy Mecm; 1969 Apr; 35(4):236-46. PubMed ID: 5810400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
